Recombinant Human SFTPC Protein (HEK293)，His

SFTPC, or Surfactant Protein C, is a critical component of pulmonary surfactant, which plays a vital role in reducing surface tension in the alveoli and is essential for normal lung function. Dysregulation or mutations in the SFTPC gene have been linked to various pulmonary disorders, including surfactant metabolism disorders and interstitial lung diseases. Given its importance, researchers have focused on generating recombinant SFTPC proteins to better understand their structure, function, and role in disease processes. By employing techniques such as gene cloning and expression in suitable systems, scientists can produce sufficient quantities of SFTPC for biochemical studies and functional assays. This research not only enhances our understanding of lung biology but also opens up potential therapeutic avenues for diseases associated with surfactant dysfunction. Additionally, the study of SFTPC in recombinant form can provide insights into protein stability, interactions with lipids, and the mechanisms underlying surfactant aggregation and function, thereby contributing to the development of novel treatments for respiratory conditions. As the need for effective therapies for lung diseases continues to grow, the investigation of SFTPC and its recombinant forms remains a significant area of interest in biomedical research.